Clincosm LogoSign in Get a demo

Castration-resistant Prostate Cancer

Showing 51 - 75 of 76
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Intermediate Risk Prostate Cancer, Castration-resistant Prostate Cancer Trial in Manchester, Oxford (ChAdOx1-MVA 5T4 vaccine,

Unknown status
  • Intermediate Risk Prostate Cancer
  • Castration-resistant Prostate Cancer
  • ChAdOx1-MVA 5T4 vaccine
  • Nivolumab Infusion [Opdivo]
  • Manchester, United Kingdom
  • +1 more
Nov 27, 2020

Cardiotoxicity and Hypertension in Non Metastatic Castration

Unknown status
  • Castration-resistant Prostate Cancer
  • No Intervention on patients
  • Pagani, Salerno, Italy
  • +1 more
Sep 23, 2020

Metastatic Castration Resistant Prostate Cancer - MAESTRO

Recruiting
  • Metastatic Prostate Cancer
  • Castration-resistant Prostate Cancer
    • Sutton, Surrey, United Kingdom
      The Royal Marsden NHSFT
    Jul 21, 2020

    Castration-resistant Prostate Cancer Trial in Sutton (Pembrolizumab)

    Recruiting
    • Castration-resistant Prostate Cancer
    • Sutton, Surrey, United Kingdom
      The Royal Marsden Hospital
    Jul 21, 2020

    Prostate Cancer, Castration-resistant Prostate Cancer Trial in Shanghai (SHR3680, SHR3162, SHR3680(Placebo))

    Active, not recruiting
    • Prostate Cancer
    • Castration-resistant Prostate Cancer
    • Shanghai, China
      Ye Dingwei
    May 12, 2020

    Castration-resistant Prostate Cancer Trial in Vancouver, Toronto (Abiraterone + prednisone, Enzalutamide)

    Completed
    • Castration-resistant Prostate Cancer
    • Vancouver, British Columbia, Canada
    • +1 more
    Jan 10, 2020

    Describe Patterns of Care and Outcomes of at High Risk After

    Completed
    • Prostate Cancer
    • +2 more
      • Algiers, Algeria
      • +92 more
      Dec 18, 2019

      Castration-resistant Prostate Cancer Trial (nab-paclitaxel, carboplatin)

      Unknown status
      • Castration-resistant Prostate Cancer
      • (no location specified)
      Oct 30, 2019

      Distant Metastases in Castration-Resistant Prostate Cancer

      Terminated
      Has Results
      • Castration-Resistant Prostate Cancer
        • Anchorage, Alaska
        • +57 more
        Jul 24, 2019

        Castration-resistant Prostate Cancer, Stage IV Prostate Cancer Trial in Singapore, United States (abiraterone acetate)

        Completed
        Has Results
        • Castration-resistant Prostate Cancer
        • Stage IV Prostate Cancer
        • abiraterone acetate
        • Atlanta, Georgia
        • +5 more
        Jul 2, 2019

        Cancer of the Prostate, Castration-resistant Prostate Cancer Trial in Cincinnati (Gadoxetate Sodium)

        Unknown status
        • Cancer of the Prostate
        • Castration-resistant Prostate Cancer
        • Gadoxetate Sodium
        • Cincinnati, Ohio
          University of Cincinnati
        May 22, 2019

        Free Psa Ratio at Biochemical Recurrence After Radical

        Completed
        • Metastasis
        • +2 more
        • Free PSA ratio test in patients after definitive treatment for localized prostate cancer
        • Toronto, Ontario, Canada
          Princess Margaret Cancer Center
        Apr 22, 2019

        Prostate Cancer Metastatic, Hormone Refractory Prostate Cancer, Castration-resistant Prostate Cancer Trial in United States

        Completed
        Has Results
        • Prostate Cancer Metastatic
        • +2 more
        • sipuleucel-T
        • abiraterone acetate
        • La Jolla, California
        • +20 more
        Mar 5, 2019

        Castration-resistant Prostate Cancer, CRPC Trial in Worldwide (Seviteronel: given orally once daily in 28 day cycles)

        Completed
        • Castration-resistant Prostate Cancer
        • CRPC
        • Seviteronel: given orally once daily in 28 day cycles
        • Homewood, Alabama
        • +22 more
        Jan 31, 2019

        Castration-resistant Prostate Cancer, CRPC Trial in United States (VT-464: given orally once daily in 28 day cycles)

        Completed
        • Castration-resistant Prostate Cancer
        • CRPC
        • VT-464: given orally once daily in 28 day cycles
        • Tampa, Florida
        • +4 more
        Jan 31, 2019

        Castration-Resistant Prostate Cancer Trial in Worldwide (Enzalutamide, Placebo)

        Completed
        Has Results
        • Castration-Resistant Prostate Cancer
        • Birmingham, Alabama
        • +248 more
        Nov 15, 2018

        Adenocarcinoma of the Prostate, Castration-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Seattle (Cabozantinib)

        Terminated
        Has Results
        • Adenocarcinoma of the Prostate
        • +4 more
        • Seattle, Washington
          Seattle Cancer Care Alliance/University of Washington
        Nov 6, 2018

        Castration-Resistant Prostate Cancer, Prostate Cancer Trial in Tbilisi, Moscow (Enzalutamide)

        Completed
        • Castration-Resistant Prostate Cancer
        • Prostate Cancer
        • Tbilisi, Georgia
        • +3 more
        Oct 15, 2018

        Castration-resistant Prostate Cancer, Prostate Cancer Metastatic Trial in Tianjin (Luminal type-1, Luminal type-2,

        Recruiting
        • Castration-resistant Prostate Cancer
        • Prostate Cancer Metastatic
        • Luminal type-1
        • +5 more
        • Tianjin, China
          Tianjin Medical Unversity Second Hospital
        Oct 4, 2018

        Predictive Nomogram of CRPC

        Unknown status
        • Castration-resistant Prostate Cancer
        • Metastatic Cancer
          • Tianjin, China
            Tianjin Medical Unversity Second Hospital
          Sep 27, 2018

          Prostate Cancer, Castration-resistant Prostate Cancer Trial in Naples (Cabazitaxel, Prednisone)

          Unknown status
          • Prostate Cancer
          • Castration-resistant Prostate Cancer
          • Naples, Italy
            University Federico II of Naples
          Dec 13, 2017

          Prostate Cancer, Castration-resistant Prostate Cancer, Drug Trial (Abiraterone Acetate, Docetaxel)

          Unknown status
          • Prostate Cancer
          • +2 more
          • (no location specified)
          Nov 22, 2017

          Bone Metastases, Castration-Resistant Prostate Cancer Trial in France, United States (Radium-223 dichloride (Xofigo,

          Completed
          Has Results
          • Bone Metastases
          • Castration-Resistant Prostate Cancer
          • Radium-223 dichloride (Xofigo, BAY88-8223)
          • Docetaxel
          • San Francisco, California
          • +6 more
          Nov 11, 2016

          Castration-resistant Prostate Cancer Trial in Grenoble (F-Choline-PET)

          Terminated
          • Castration-resistant Prostate Cancer
          • F-Choline-PET
          • Grenoble, France
          • +2 more
          Apr 27, 2016

          Prostate Cancer, Castration-resistant Prostate Cancer Trial in Washington, Baltimore, Detroit (Itraconazole, Orteronel)

          Withdrawn
          • Prostate Cancer
          • Castration-resistant Prostate Cancer
          • Washington, District of Columbia
          • +2 more
          Jul 22, 2014